Suchergebnisse - "Paradis, Valérie"

PubPharm (17)

1

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma : a multicentre retrospective study

enthalten in: The Lancet. Oncology | 2023

von Zeng, Q. | Klein, C. | Caruso, S. | +119

2

Hepatocyte-derived biomarkers predict liver-related events at 2 years in Child-Pugh class A alcohol-related cirrhosis

enthalten in: Journal of hepatology | 2023

von Elkrief, L. | Ganne-Carrié, N. | Manceau, H. | +20

3

Quantitative imaging predicts pancreatic fatty infiltration on routine CT examination

enthalten in: Diagnostic and interventional imaging | 2023

von Previtali, C. | Sartoris, R. | Rebours, V. | +8

4

Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH : A development and validation study

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Lee, J. | Westphal, M. | Vali, Y. | +139

5

Reply to : Correspondence regarding "Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies"

enthalten in: Journal of hepatology | 2022

von Beaufrère, A. | Vilgrain, V. | Paradis, V.

CommentOn: J Hepatol. 2022 Feb;76(2):343-352. - PMID 34624411

6

The triglycerides and glucose (TyG) index : A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients

enthalten in: Diabetes & metabolism | 2022

von Rivière, B. | Jaussent, A. | Macioce, V. | +15

7

Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma

enthalten in: The British journal of surgery | 2022

von Hobeika, C. | Guyard, C. | Sartoris, R. | +20

CommentIn: Br J Surg. 2022 Oct 14;109(11):e119. - PMID 35979542

8

Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies

enthalten in: Journal of hepatology | 2022

von Beaufrère, A. | Caruso, S. | Calderaro, J. | +7

CommentIn: J Hepatol. 2022 Sep;77(3):890-891. - PMID 35421425

9

International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma

enthalten in: Gastroenterology | 2021

von Singal, A. | Hoshida, Y. | Pinato, D. | +12

10

Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma

enthalten in: European journal of gastroenterology & hepatology | 2020

von Payancé, A. | Dioguardi Burgio, M. | Peoc'h, K. | +10